Author:
Uygunoglu Ugur,Gunduz Aysegul,Menku Sukriye F,Yilmaz Basak,Hatipoglu Esra,Yalcinkaya Cengiz,Saip Sabahattin,Apaydin Hulya
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Reference17 articles.
1. Cali JJ, Hsieh CL, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 1991;266:7779–83.
2. Moghadasian MH. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. Clin Invest Med. 2004;27:42–50.
3. Federico A, Dotti MT, Gallus GN. Cerebrotendinous xanthomatosis. In: Pagon RA, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. Gene reviews. Seattle, WA: University of Washington; 2013. p. 1993–2003.
4. Barkhof F, Verrips A, Wesseling P, van Der Knaap MS, van Engelen BG, Gabreëls FJ, et al. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology. 2000;217:869–76.
5. Salen G, Berginer V, Shore V, Horak I, Horak E, Tint GS. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid. N Engl J Med. 1987;316:1233–8.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献